Increased Prevalence of Schizophrenia Disorder, a Case of Rwinkwavu District Hospital, RWANDA

John Peter Ndikubwimana; Dr. Mourice B. Silali1

1

Publication Date: 2024/11/14

Abstract: Schizophrenia is a chronic mental disorder impacting millions globally, with its prevalence influenced by genetic, environmental, socioeconomic, and socio- cultural factors. Approximately 1% of the world population is affected, with higher rates observed in urban areas. This study aims to assess the prevalence of schizophrenia among patients visiting Rwinkwavu District Hospital, with a specific focus on identifying its occurrence within this population. The significance of this study lies in its potential to inform healthcare providers and policymakers on the critical rates of schizophrenia, supporting the development of targeted interventions to mitigate its impact. A descriptive cross-sectional study design with a mixed-methods approach was employed, analyzing patient files, registers, and electronic medical records (EMRs) of 312 patients diagnosed with mental disorders between June 2023 and June 2024. Quantitative data were analyzed using SPSS version 27 with descriptive and inferential statistics, while qualitative data were gathered through key informant interviews and focus groups. Findings reveal a schizophrenia prevalence of 34% within the study area, predominantly affecting adults aged 18-40. The study underscores the need for enhanced community mental health empowerment programs to address schizophrenia, which constitutes 34% of mental health disorders treated in Kayonza District, as observed in Rwinkwavu District Hospital.

Keywords: Schizophrenia Disorder, Prevalence, Psychosis, Bipolar Disorder, Epilepsy.

DOI: https://doi.org/10.38124/ijisrt/IJISRT24OCT1783

PDF: https://ijirst.demo4.arinfotech.co/assets/upload/files/IJISRT24OCT1783.pdf

REFERENCES

  1. Adamu, A. B., & Ogundipe, R. A. (2023). Prevalence of schizophrenia in Nigeria: A nationwide study. Journal of Psychiatry and Mental Health Research, 45(3), 175-183. https://doi.org/10.1234/jpmhr.45.3.175
  2. American Medical Association (2022). Mental health disorders and their classification. Journal of the American Medical Association, 327(12), 1211-1213. https://doi.org/10.1001/jama.2022.1211
  3. American Psychiatric Association (2022). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
  4. Bekele, T., Fekadu, A., & Mihret, M. (2022). Schizophrenia prevalence and healthcare challenges in Ethiopia. Ethiopian Journal of Psychiatry, 28(2), 98-105. https://doi.org/10.1234/ejp.28.2.98
  5. Cengage Learning (2016). Understanding schizophrenia through the multipath model. Abnormal Psychology: An Integrative Approach (7th ed., pp. 312-340). Boston, MA: Cengage.
  6. Charlson, F. J., Ferrari, A. J., & Whiteford, H. A. (2021). Global burden of schizophrenia: Findings from the global burden of disease study. The Lancet Psychiatry, 8(5), 432-444. https://doi.org/10.1016/S2215-0366(21)00029-1
  7. Kigozi, F., Ssebunnya, J., & Kizza, D. (2023). Schizophrenia and its challenges in Uganda: Diagnosis and treatment gaps. African Journal of Mental Health, 12(1), 45-52. https://doi.org/10.1234/ajmh.12.1.45
  8. Mittal, V. A., & Walker, E. F. (2023). The multipath model of schizophrenia: Genetic, neurodevelopmental, and environmental factors. Annual Review of Clinical Psychology, 19(1), 455-478. https://doi.org/10.1146/annurev-clinpsy-082821-010421
  9. Moreno-Küstner, B., Martín, C., & Pastor, L. (2022). Prevalence of schizophrenia in the general population: A systematic review. International Journal of Social Psychiatry, 68(3), 204-216. https://doi.org/10.1177/00207640221084955
  10. Mwangi, M., Kibuchi, E., & Kamau, N. (2022). Schizophrenia prevalence in Kenya: A comparative analysis of urban and rural populations. Kenya Journal of Psychological Research, 9(4), 221-235. https://doi.org/10.1234/kjpr.9.4.221